CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 301 - 325 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C60450 Premalignant malignant hematopoiesis evidence dysplastic cell indicator

Indicator of the presence of dysplastic cells evidencing premalignant or malignant hematopoiesis.

Supplemental 1.00 2021-04-22 09:19:39.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60452 Premalignant malignant hematopoiesis evidence blast indicator

Indicator of the presence of blasts evidencing premalignant or malignant hematopoiesis.

Supplemental 1.00 2021-04-22 09:19:39.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60448 Bone marrow aspirate biopsy prior genetically modified hematopoietic stem cell infusion indicator

Indicator of whether bone marrow aspirate or biopsy was performed prior to infusion of genetically modified (GM) hematopoietic stem cells (HSC).

Supplemental 1.00 2021-04-21 16:53:07.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60449 Bone marrow aspirate biopsy prior genetically modified hematopoietic stem cell infusion date

Indicator of whether bone marrow aspirate or biopsy was performed prior to infusion of genetically modified (GM) hematopoietic stem cells (HSC).

Supplemental 1.00 2021-04-21 16:53:07.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60447 Hematology since previous report date status

Status of subject/participant's hematology since the date of the previous genotoxicity report.

Supplemental 1.00 2021-04-21 16:43:01.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60446 Autologous transplant genetically modified hematopoietic stem cell infusion elapsed time category

Category of time elapsed since autologous transplant (TP) and genetically modified (GM) hematopoietic stem cell (HSC) infusion.

Supplemental 1.00 2021-04-21 16:32:23.0 Genotoxicity Sickle Cell Disease Sickle Cell Disease
C60441 Laboratory procedure hemoglobin genetic modified A variant result percentage value

The percentage value related to genetic modified A variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60442 Laboratory procedure hemoglobin other variant result percentage value

The percentage value related to other variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60435 Laboratory procedure hemoglobin analysis other method specify text

The other specify related to hemoglobin method analysis type.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60443 Laboratory procedure hemoglobin result other specify text

The specify text related to other variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60436 Laboratory procedure hemoglobin S result percentage value

The percentage value related to S variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60444 Laboratory procedure alpha beta thalassemia parent result text

The text related to alpha and beta thalassemia results for parents.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60437 Laboratory procedure hemoglobin C result percentage value

The percentage value related to C variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60438 Laboratory procedure hemoglobin F result percentage value

The percentage value related to F variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60439 Laboratory procedure hemoglobin A result percentage value

The percentage value related to A variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60440 Laboratory procedure hemoglobin A2 result percentage value

The percentage value related to A2 variant hemoglobin.

Core 1.00 2021-04-11 01:51:27.0 Genetic Diagnostic Testing Sickle Cell Disease Sickle Cell Disease
C60432 School work missed prior month day count

The count of days in prior month of missed work or school.

Supplemental 1.00 2021-04-09 01:41:23.0 Social Status Sickle Cell Disease Sickle Cell Disease
C60433 School work missed prior year day count

The count of days in prior year of missed work or school.

Supplemental 1.00 2021-04-09 01:41:23.0 Social Status Sickle Cell Disease Sickle Cell Disease
C60431 Imaging repetition duration

Duration (in milliseconds) of the repetition time (TR) used in imaging acquisition.

Supplemental 1.00 2021-04-08 15:07:14.0 Silent Cerebral Infarct Sickle Cell Disease Sickle Cell Disease
C60430 Imaging gap between slice percent value

Value of the percentage gap between slices in 2D imaging acquisition.

Supplemental 1.00 2021-04-08 15:01:33.0 Silent Cerebral Infarct Sickle Cell Disease Sickle Cell Disease
C60429 Imaging in plane resolution measurement

Measurement (in square millimeters) of the in-plane resolution of the imaging.

Supplemental 1.00 2021-04-08 14:58:11.0 Silent Cerebral Infarct Sickle Cell Disease Sickle Cell Disease
C60428 Imaging field of view measurement

Measurement (in square millimeters) of the field of view of the imaging.

Supplemental 1.00 2021-04-08 14:56:00.0 Silent Cerebral Infarct Sickle Cell Disease Sickle Cell Disease
C60427 Imaging MRI parameter sequence type

Type of magnetic resonance imaging (MRI) for which sequence parameters are being recorded.

Supplemental 1.00 2021-04-08 14:49:02.0 Silent Cerebral Infarct Sickle Cell Disease Sickle Cell Disease
C60421 Red blood cell dense percentage value

The percentage related to dense red blood cells.

Exploratory 1.00 2021-04-08 01:30:05.0 Adhesion and Viscosity Sickle Cell Disease Sickle Cell Disease
C60422 Red blood cell dense assessment type

The type of assessment as related to dense red blood cells.

Exploratory 1.00 2021-04-08 01:30:05.0 Adhesion and Viscosity Sickle Cell Disease Sickle Cell Disease
Displaying 301 - 325 of 5231